Squarepoint Ops LLC Cor Medix Inc. Transaction History

Squarepoint Ops LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$3.0 - $4.01 $231,198 - $309,034	77,066 New	77,066 $289,000
Q1 2023 May 15, 2023	BUY	$3.22 - $4.61 $84,621 - $121,150	26,280 New	26,280 $108,000
Q2 2021 Aug 16, 2021	SELL	$6.05 - $10.09 $134,763 - $224,754	-22,275 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$6.84 - $17.58 $152,361 - $391,594	22,275 New	22,275 $223,000
Q2 2019 Aug 14, 2019	SELL	$5.93 - $10.57 $101,652 - $181,190	-17,142 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$6.95 - $13.25 $119,136 - $227,131	17,142 New	17,142 $162,000

120

18.3M

134K

441K

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $405M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.